Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Are Dumping E I Du Pont De Nemours And Co (DD)

Page 1 of 2

E I Du Pont De Nemours And Co (NYSE:DD) has experienced a decrease in enthusiasm from smart money recently.

In the 21st century investor’s toolkit, there are a multitude of gauges market participants can use to track publicly traded companies. Two of the most useful are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best hedge fund managers can outperform the broader indices by a superb amount (see just how much).

E I Du Pont De Nemours And CoJust as important, optimistic insider trading sentiment is a second way to parse down the world of equities. Just as you’d expect, there are plenty of reasons for a bullish insider to cut shares of his or her company, but just one, very obvious reason why they would behave bullishly. Many academic studies have demonstrated the valuable potential of this strategy if shareholders know what to do (learn more here).

Now, let’s take a look at the recent action regarding E I Du Pont De Nemours And Co (NYSE:DD).

How have hedgies been trading E I Du Pont De Nemours And Co (NYSE:DD)?

At Q1’s end, a total of 26 of the hedge funds we track were long in this stock, a change of -21% from one quarter earlier. With the smart money’s capital changing hands, there exists an “upper tier” of key hedge fund managers who were upping their stakes significantly.

Of the funds we track, Levin Capital Strategies, managed by John A. Levin, holds the biggest position in E I Du Pont De Nemours And Co (NYSE:DD). Levin Capital Strategies has a $153 million position in the stock, comprising 2.7% of its 13F portfolio. Coming in second is Steven Cohen of SAC Capital Advisors, with a $46.7 million position; 0.2% of its 13F portfolio is allocated to the company. Other hedge funds that hold long positions include Ken Griffin’s Citadel Investment Group, and D. E. Shaw’s D E Shaw.

Seeing as E I Du Pont De Nemours And Co (NYSE:DD) has experienced bearish sentiment from the entirety of the hedge funds we track, we can see that there lies a certain “tier” of hedge funds who sold off their positions entirely at the end of the first quarter. Interestingly, Phill Gross and Robert Atchinson’s Adage Capital Management cut the largest position of the 450+ funds we track, valued at close to $27.8 million in stock., and Matthew Tewksbury of Stevens Capital Management was right behind this move, as the fund said goodbye to about $17.9 million worth. These transactions are important to note, as total hedge fund interest fell by 7 funds at the end of the first quarter.

How have insiders been trading E I Du Pont De Nemours And Co (NYSE:DD)?

Bullish insider trading is particularly usable when the company in focus has seen transactions within the past half-year. Over the latest six-month time frame, E I Du Pont De Nemours And Co (NYSE:DD) has experienced zero unique insiders buying, and 8 insider sales (see the details of insider trades here).

Let’s also take a look at hedge fund and insider activity in other stocks similar to E I Du Pont De Nemours And Co (NYSE:DD). These stocks are FMC Corp (NYSE:FMC), Eastman Chemical Company (NYSE:EMN), Sociedad Quimica y Minera (ADR) (NYSE:SQM), Air Products & Chemicals, Inc. (NYSE:APD), and The Dow Chemical Company (NYSE:DOW). This group of stocks are in the chemicals – major diversified industry and their market caps resemble DD’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!